This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

SAM-e

SAM-e is the universal methyl donor — a single biochemical currency that the body spends on neurotransmitter synthesis (serotonin, dopamine, norepinephrine, melatonin), DNA methylation, phosphatidy…

Aliases (5)
SAM-e · SAME · S-Adenosyl-L-Methionine · S-Adenosylmethionine · AdoMet
TYPICAL DOSE
200-400 mg AM on empty stomach (≥30 min before …
ROUTE
CYCLE
STORAGE

Overview

What is SAM-e?

SAM-e is the universal methyl donor — a single biochemical currency that the body spends on neurotransmitter synthesis (serotonin, dopamine, norepinephrine, melatonin), DNA methylation, phosphatidylcholine production, joint proteoglycan synthesis, and Phase II liver detox. As a supplement, it has three real-world use cases backed by clinical trials: (1) mild-to-moderate depression — efficacy comparable to imipramine and escitalopram in pooled 2024 meta-analyses (PMIDs 38423354, 38199136), with faster onset and better tolerability than SSRIs; (2) osteoarthritis — pain reduction comparable to celecoxib and NSAIDs without GI ulceration risk (PMIDs 12019049, 15102339); (3) intrahepatic cholestasis / alcoholic liver disease — modest but reproducible hepatoprotection (PMID 22659519). For a 20-year-old MMA athlete with no depressive episodes, no joint disease, and untested methylation status, SAM-e is OPTIONAL-ADD, LOW-PRIORITY — keep it on the shelf as a situational tool for post-fight emotional letdown, a future MTHFR C677T finding with elevated homocysteine on bloodwork, or oral-steroid liver protection (paired with TUDCA). Hard blocks: bipolar (mania risk), current SSRI/SNRI/MAOI/tramadol user (serotonin syndrome risk). Enteric coating is non-negotiable — non-coated SAM-e degrades in stomach acid (<1% bioavailability).

Peptide Interactions

Methyl-B12 (methylcobalamin) + methyl-folate (5-MTHF):
Synergistic

Essential co-supplements. Prevent paradoxical homocysteine elevation. The MTHF + methyl-B12 + SAM-e triad is the foundational methylation stack.

P5P (pyridoxal-5-phosphate / active B6):
Synergistic

Required for transsulfuration arm — clears homocysteine via cystathionine β-synthase. Especially relevant in CBS variants.

TMG (trimethylglycine / betaine):
Synergistic

Alternative methyl donor and homocysteine remethylation pathway (BHMT). Synergistic for methylation support; particularly useful in MTHFR carriers.

TUDCA (tauroursodeoxycholic acid):
Synergistic

Synergistic for liver protection — different mechanism (bile-acid signaling vs methyl donation). Standard stack for oral anabolic steroid users.

Omega-3 (EPA/DHA):
Synergistic

Independent antidepressant effects + methylation-supportive (DHA is a substrate for SAM-e-dependent methylation in neuronal membranes). Adjunctive in depress…

Magnesium:
Synergistic

Cofactor for ATP regeneration → methionine adenosyltransferase activity. Generic supportive role.

L-theanine:
Synergistic

Counters the activation/anxiety subset effect for users who get jittery on SAM-e. Anecdotal but well-tolerated.

SSRIs / SNRIs / MAOIs / tramadol / triptans / St. John's Wort / 5-HTP at high dose:
Avoid

Serotonin syndrome risk. Medical supervision required.

Levodopa (without carbidopa adjustment):
Avoid

SAM-e can methylate L-dopa via COMT, reducing efficacy. Parkinson's patients on L-dopa need physician oversight.

Niacin (large doses, >500 mg):
Avoid

Niacin is a methyl-group sink (NNMT converts nicotinamide to N-methylnicotinamide using SAM-e). High-dose niacin can deplete SAM-e — counterproductive.

MAOI-B inhibitors (selegiline):
Avoid

Methylation pathway interactions; possible serotonin syndrome risk.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.

Side Effects & Safety

Common (5-15%):

  • GI upset — nausea, mild stomach discomfort (usually transient, week 1-2)
  • Insomnia / activation if dosed PM (move to AM)
  • Headache (mild, dose-dependent)
  • Mild anxiety / restlessness (catecholaminergic activation)
  • Dry mouth, increased sweating

Less common (1-5%):

  • Palpitations / tachycardia (catecholaminergic; usually mild and dose-related)
  • Hypomanic symptoms — irritability, racing thoughts, decreased sleep need (warning sign; reduce dose or stop)
  • Diarrhea
  • Vivid dreams (likely melatonin-pathway methylation effects)

Rare-serious (<1% but clinically important):

  • Manic switch in bipolar individuals — HARD BLOCK. Same risk pattern as SSRIs (10-30% in untreated bipolar I); possibly faster onset given direct catecholamine substrate provision. SAM-e can precipitate mania in bipolar individuals who were not yet diagnosed — first manic episode under SAM-e is documented in case reports. Bipolar I and bipolar II are both at risk; cyclothymia probably similar.
  • Serotonin syndrome with serotonergic drugs. Theoretical and case-documented in combination with SSRIs/SNRIs/MAOIs/tramadol/triptans/St. John's Wort. Mechanism: increased methyl supply may indirectly boost serotonin synthesis, plus direct effects on monoamine availability. Hard interaction; medical supervision required if combining.
  • Paradoxical homocysteine elevation. SAM-e supplementation increases SAH (S-adenosyl-homocysteine) which is hydrolyzed to homocysteine. Without adequate B12, folate, B6 cofactors to recycle homocysteine, plasma homocysteine can paradoxically rise. Always pair SAM-e with methyl-B12 + methyl-folate (or 5-MTHF) and B6/P5P, especially in MTHFR carriers.
  • Anxiety amplification in pre-existing anxiety disorders. Some users with GAD or panic disorder report worsening; mechanism is catecholaminergic activation.
  • Allergic skin reactions (rare, idiosyncratic).

Specific watch periods:

  • Days 1-7: Activation symptoms (anxiety, insomnia, GI). Reduce dose if intolerable; titrate slower.
  • Weeks 2-6: Mood-response window. Hypomania warning signs require dose hold and re-evaluation.
  • Months 3-6: Methyl-cycle cofactor depletion can present as fatigue, low mood — paradoxical "burnout." Check B12, folate, homocysteine.

References

Limveeraprajak et al. 2024 — SAMe for depression meta-analysis (23 RCTs, 2,183 participants)

pubmed.ncbi.nlm.nih.gov · 2024

PMID 38423354

View Study

Peng et al. 2024 — SAMe adjuvant for depression meta-analysis (14 RCTs, 1,522 participants)

pubmed.ncbi.nlm.nih.gov · 2024

PMID 38199136

View Study

Galizia et al. 2016 — Cochrane SAMe for depression review

pubmed.ncbi.nlm.nih.gov · 2016

PMID 27727432

View Study

Sarris et al. 2014 — SAMe vs escitalopram vs placebo Australian RCT

pubmed.ncbi.nlm.nih.gov · 2014

PMID 24856557

View Study

Sarris et al. 2015 — Sex-modified SAMe response in depression

pubmed.ncbi.nlm.nih.gov · 2015

PMID 26011569

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources